NUvention: Medical Advisory Board
Cindy ClagueDirector, Research and Advanced Technology at Medtronic
Dr. Cindy Clague is research director for Medtronic Structural Heart. In her most recent role, Clague leads a team of innovative scientists and engineers focused on concept evaluation, technical feasibility, anatomical characterization, and in-vivo and ex-vivo animal model creation with a near term focus on the development of transcatheter valve technologies. She has filed more than 20 patents and has more than 30 technical publications and presentations. She holds a BS in mechanical engineering from Northwestern and a PhD in biomedical engineering from the University of Minnesota.
Robert DeSutterGlobal Group Head, Piper Jaffary
Robert DeSutter is a managing director and global group head of Piper Jaffray healthcare investment banking. He oversees a team of investment bankers in New York, Minneapolis, San Francisco and London. DeSutter established the firm’s healthcare advisory practice in 1996 and has transaction experience on numerous buy- and sell-side; friendly and hostile; strategic and financial buyer; and public and private deals on a global basis. DeSutter has completed financing transactions involving public and private equity, convertible debt, subordinated debt and senior secured debt. He has also completed several Piper Jaffray merchant banking private equity investments in healthcare since 2007. DeSutter is a graduate of the University of Minnesota and the University of Virginia's Darden Graduate School of Business.
James GreenPresident and CEO of Analogic Corporation
James Green joined Analogic in 2007. Before joining, Green was regional vice president for Quest Diagnostics, a leading provider of diagnostic testing, information, and services. Before that, he was senior vice president and general manager of computed tomography for Philips Medical Systems. Prior to Phillips, Green was senior vice president, product development, at Marconi Medical, which was acquired by Philips Medical in 2001. Green earned a bachelor of science degree in electrical engineering from the University of Missouri, and a master of science degree in computer engineering from the University of Southern California.
Ronald A. MatricariaFormer CEO of St. Jude’s Medical
Ronald A. Matricaria has over 35 years of medical device and pharmaceutical experience at St. Jude Medical, Inc. and Eli Lilly and Company, Inc. He has served as president and chief executive officer of St. Jude Medical, Inc. and executive vice president of the Pharmaceutical Division of Eli Lilly and Company. Matricaria currently serves on the boards of LIFE Technology, Inc., Phoenix Children's Hospital and Volcano, Inc. where he also serves as its Chairman of the Board. Matricaria holds a bachelor’s degree in pharmacy from Massachusetts College of Pharmacy and was awarded honorary degrees in pharmacy.
Evan NortonManaging Director of Abbott Ventures Investments
Evan Norton joined Abbott Ventures in 2010. Prior to Abbott Ventures, he was a principal with ONSET Ventures focused on medical technology investing. He has a diverse background of experience in medical technology including the orthopedics, diabetes, ear, nose, and throat markets. Norton also worked at Acclarent, Inc. and Johnson & Johnson's diabetes company, LifeScan Inc. Norton holds an MBA degree from the Kellogg Graduate School of Management and a BBA in finance from Texas A&M University, cum laude.
Edward F. VoborilChairman, Greatbatch, Inc.
Edward F. Voboril served as chairman of the board of Greatbatch, Inc. from 1997 to 2008 and served as that company's president and chief executive officer from 1990 to 2006. Previously, Voboril served as vice president and general manager of the Biomedical Division of PPG Industries and held senior executive positions in the medical businesses of Honeywell, General Electric, Syntex, and Litton Industries. Voboril long served as faculty chair of NUvention: Medical, the original NUvention course offering. Mr. Voboril is lead independent director of Iris International, Inc., a supplier of in vitro diagnostic products, where he has been a director since 2008.
Barry WeitznerDirector of Research and Development at Boston Scientific Corporation
Barry Weitzner is a director of corporate research at Boston Scientific. Weitzner has over nine years of experience with Boston Scientific in the design and development of minimally invasive technologies for surgery, gastroenterology, and endoscopy. In his previous role as director of surgical endoscopy for the Boston Scientific Endoscopy Division, he led the invention and development of remote instrument control systems. Prior to Boston Scientific, Weitzner led the Research and Development teams at a number of medical device and biotechnology companies.
Andy CampbellVice President, Research and Development Heart Valve Technology at Edwards Lifesciences
Andy Campbell is the vice president of research development for Edwards Lifesciences, a role in which he leads the advancement of minimally invasive valve replacement technology. He previously served as the senior director of research and development for heart valve replacement and repair devices at Medtronic, Inc. He is a member of the Japanese Artificial Organs Society, the University of Iowa biomedical engineering advisory board and the Society for Heart Valve Disease. Campbell received his MBA and a bachelor's degree in mechanical engineering from the University of Texas at Austin.